Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM
NCT ID: NCT03544411
Last Updated: 2018-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
10 participants
INTERVENTIONAL
2018-07-02
2018-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Intervention: Patient type 2 DM will receive olive oil and bran oil with cross over study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Daily Consumption of Extra Virgin Olive Oil on Blood Glucose Among Diabetic Patients
NCT03447301
Antidiabetic Effect of Olive Pomace Oil
NCT06723886
Extra Virgin Olive Oil on Glycemic Control ,Insulin Resistance and Insulin Secretion
NCT03891927
Effect of Extra Virgin Olive Oil on Postprandial Blood Glucose in Type 2 Diabetes Mellitus Patients
NCT04077216
Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM
NCT04419948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study was a clinical trial with cross over study design, random allocation, and double blindness to compare changes in antioxidant, glucose, cholesterol and triglyceride levels supplemented with 15 ml / day of olive oil (KZ) with supplementation of 15 ml / day of bran oil (KB). Provision of oil for 4 weeks in a row. During the 2-week interval not being treated (wash out). After the wash out period cross-over by exchanging olive oil supplementation to rice bran and vice versa for 4 consecutive weeks. The research will be conducted at Family Clinic Clinic FKUI Kayu Putih, Jakarta.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 2 Diabetes Mellitus group 1
The group supplemented with 15 ml / day of olive oil and 15 ml / day of bran oil
olive oil
the intervention consist of 15 ml / day of olive oil
bran oil
the intervention consist of 15 ml / day of bran oil
Type 2 Diabetes Mellitus group 2
this group supplemented with 15 ml / day of olive oil and 15 ml / day of bran oil
olive oil
the intervention consist of 15 ml / day of olive oil
bran oil
the intervention consist of 15 ml / day of bran oil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
olive oil
the intervention consist of 15 ml / day of olive oil
bran oil
the intervention consist of 15 ml / day of bran oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed type 2 DM \<3 years.
* Body mass index of 20-30 kg / m2
* Subjects willing to participate in research and sign informed consent.
* Drinking OHO (oral hyperglycemic medication).
Exclusion Criteria
* Subject is pregnant.
* Get cholesterol-lowering drugs, steroids and other drugs that affect the metabolism of fat.
* Smoking more than 10 cigarettes / day.
* Eat regular supplements that contain phytosterols or other antioxidants that are known by anamnesis.
* Has a disorder or gastrointestinal disease, thyroid, heart, liver, cancer, stroke and kidney are known with medical record data.
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fakultas Kedokteran Universitas Indonesia
OTHER
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rina Agustina
Head of Human Nutrition Research Centre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dwirini R Gunarti, DR
Role: PRINCIPAL_INVESTIGATOR
Indonesia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fkui-Kdk Kiara
Jakarta Pusat, DKI Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BeZaproject
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.